Efficacy and Safety of Vonoprazan Compared to Lansoprazole in Participants With Erosive Esophagitis

  • STATUS
    Recruiting
  • End date
    Aug 1, 2021
  • participants needed
    1000
  • sponsor
    Phathom Pharmaceuticals, Inc.
Updated on 16 December 2020
Investigator
Phathom Medical Information
Primary Contact
Clinical Associates Research (7.7 mi away) Contact
+126 other location

Summary

To evaluate the efficacy and safety of vonoprazan compared to lansoprazole in participants with erosive esophagitis.

Details
Treatment lansoprazole, Vonoprazan
Clinical Study IdentifierNCT04124926
SponsorPhathom Pharmaceuticals, Inc.
Last Modified on16 December 2020

Adding a note
adding personal notes guide

Select a piece of text and start making personal notes.

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

Study

user name

Annotated by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No made yet